Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance? (Q51239492)

1 April 2018

title

Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance? (English)

1 reference

1 April 2018

author name string

Michael Hölzel

series ordinal

1

1 reference

1 April 2018

Anton Bovier

series ordinal

2

1 reference

1 April 2018

Thomas Tüting

series ordinal

3

1 reference

1 April 2018

language of work or name

English

0 references

publication date

28 March 2013

1 reference

1 April 2018

published in

Nature Reviews Cancer

1 reference

1 April 2018

volume

13

1 reference

1 April 2018

issue

5

1 reference

1 April 2018

page(s)

365-376

1 reference

1 April 2018

Hallmarks of Cancer: The Next Generation

cites work

1 reference

Management of cutaneous melanoma

31 March 2020

1 reference

Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma

31 March 2020

1 reference

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

31 March 2020

1 reference

Improved survival with MEK inhibition in BRAF-mutated melanoma

31 March 2020

1 reference

Melanoma: from mutations to medicine

31 March 2020

1 reference

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

31 March 2020

1 reference

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

31 March 2020

1 reference

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

31 March 2020

1 reference

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

31 March 2020

1 reference

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

31 March 2020

1 reference

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

31 March 2020

1 reference

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

31 March 2020

1 reference

Intra-tumour heterogeneity: a looking glass for cancer?

31 March 2020

1 reference

Cancer as an evolutionary and ecological process

31 March 2020

1 reference

How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine

31 March 2020

1 reference

Clonal evolution in cancer

31 March 2020

1 reference

Evolutionary dynamics of carcinogenesis and why targeted therapy does not work.

31 March 2020

1 reference

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery

31 March 2020

1 reference

The therapeutic promise of the cancer stem cell concept

31 March 2020

1 reference

The cancer stem cell: premises, promises and challenges

31 March 2020

1 reference

Cancer stem cells: impact, heterogeneity, and uncertainty

31 March 2020

1 reference

Dormancy of metastatic melanoma

31 March 2020

1 reference

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

31 March 2020

1 reference

Resistance, epigenetics and the cancer ecosystem

31 March 2020

1 reference

Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance

31 March 2020

1 reference

Tumors as organs: complex tissues that interface with the entire organism

31 March 2020

1 reference

The tumor microenvironment is a dominant force in multidrug resistance.

31 March 2020

1 reference

Environment-mediated drug resistance: a major contributor to minimal residual disease

31 March 2020

1 reference

Accessories to the crime: functions of cells recruited to the tumor microenvironment

31 March 2020

1 reference

Multidrug resistance in cancer: role of ATP-dependent transporters

31 March 2020

1 reference

Timeline: Chemotherapy and the war on cancer.

31 March 2020

1 reference

Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients

31 March 2020

1 reference

MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling

31 March 2020

1 reference

DNA damage-mediated induction of a chemoresistant niche

31 March 2020

1 reference

Chemotherapeutic resistance: surviving stressful situations

31 March 2020

1 reference

Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer

31 March 2020

1 reference

Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance

31 March 2020

1 reference

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy

31 March 2020

1 reference

A CXCL1 paracrine network links cancer chemoresistance and metastasis

31 March 2020

1 reference

Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

31 March 2020

1 reference

Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth

31 March 2020

1 reference

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

31 March 2020

1 reference

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

31 March 2020

1 reference

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

31 March 2020

1 reference

BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet

31 March 2020

1 reference

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib

31 March 2020

1 reference

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

31 March 2020

1 reference

Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor

31 March 2020

1 reference

Pretreatment EGFR T790M Mutation and BRCA1 mRNA Expression in Erlotinib-Treated Advanced Non–Small-Cell Lung Cancer Patients with EGFR Mutations

31 March 2020

1 reference

Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer.

31 March 2020

1 reference

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.

31 March 2020

1 reference

EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib

31 March 2020

1 reference

Pushing the limits of targeted therapy in chronic myeloid leukaemia.

31 March 2020

1 reference

Gatekeeper mutations mediate resistance to BRAF-targeted therapies.

31 March 2020

1 reference

Mutant BRAF Melanomas—Dependence and Resistance

31 March 2020

1 reference

COT drives resistance to RAF inhibition through MAP kinase pathway reactivation

31 March 2020

1 reference

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

31 March 2020

1 reference

Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K

31 March 2020

1 reference

Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance

31 March 2020

1 reference

Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors.

31 March 2020

1 reference

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

31 March 2020

1 reference

Scatter factor/hepatocyte growth factor as a regulator of skeletal muscle and neural crest development

31 March 2020

1 reference

Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor

31 March 2020

1 reference

Crosstalk to stromal fibroblasts induces resistance of lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors

31 March 2020

1 reference

Hepatocyte growth factor expression in EGFR mutant lung cancer with intrinsic and acquired resistance to tyrosine kinase inhibitors in a Japanese cohort.

31 March 2020

1 reference

Cancer immunotherapy: a treatment for the masses

31 March 2020

1 reference

Cancer immunotherapy comes of age

31 March 2020

1 reference

Progress in human tumour immunology and immunotherapy

31 March 2020

1 reference

Human T cell responses against melanoma

31 March 2020

1 reference

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993

31 March 2020

1 reference

Cancer immunotherapy: moving beyond current vaccines

31 March 2020

1 reference

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

31 March 2020

1 reference

Adoptive T cell therapy using antigen-specific CD8 T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

31 March 2020

1 reference

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

31 March 2020

1 reference

Phase I study of adoptive T-cell therapy using antigen-specific CD8 T cells for the treatment of patients with metastatic melanoma.

31 March 2020

1 reference

Transferred melanoma-specific CD8 T cells persist, mediate tumor regression, and acquire central memory phenotype

31 March 2020

1 reference

Adoptive immunotherapy for cancer: harnessing the T cell response

31 March 2020

1 reference

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

31 March 2020

1 reference

Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy

31 March 2020

1 reference

Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma

31 March 2020

1 reference

Identification of multiple antigens recognized by tumor-infiltrating lymphocytes from a single patient: tumor escape by antigen loss and loss of MHC expression

31 March 2020

1 reference

Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8 T cells in patients with melanoma

31 March 2020

1 reference

New generation vaccine induces effective melanoma-specific CD8 T cells in the circulation but not in the tumor site

31 March 2020

1 reference

Exhaustion of tumor-specific CD8 T cells in metastases from melanoma patients

31 March 2020

1 reference

31 March 2020

1 reference

Tumor-initiated inflammation overrides protective adaptive immunity in an induced melanoma model in mice.

31 March 2020

1 reference

Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model

31 March 2020

1 reference

Immunosuppressive networks in the tumour environment and their therapeutic relevance

31 March 2020

1 reference

Immunosuppressive strategies that are mediated by tumor cells

31 March 2020

1 reference

Creating immune privilege: active local suppression that benefits friends, but protects foes.

31 March 2020

1 reference

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

31 March 2020

1 reference

Complete regression of advanced primary and metastatic mouse melanomas following combination chemoimmunotherapy.

31 March 2020

1 reference

Autochthonous primary and metastatic melanomas in Hgf-Cdk4 R24C mice evade T-cell-mediated immune surveillance.

31 March 2020

1 reference

Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation

31 March 2020

1 reference

Molecular plasticity of human melanoma cells

31 March 2020

1 reference

Melanocytes in development, regeneration, and cancer

31 March 2020

1 reference

Melanoma revives an embryonic migration program to promote plasticity and invasion

31 March 2020

1 reference

Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized

31 March 2020

1 reference

Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271

31 March 2020

1 reference

Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth

31 March 2020

1 reference

In vivo switching of human melanoma cells between proliferative and invasive states

31 March 2020

1 reference

Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination

31 March 2020

1 reference

A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth

31 March 2020

1 reference

GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells

31 March 2020

1 reference

Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny.

31 March 2020

1 reference

Systematic classification of melanoma cells by phenotype-specific gene expression mapping.

31 March 2020

1 reference

Immunoediting of cancers may lead to epithelial to mesenchymal transition.

31 March 2020

1 reference

Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells

31 March 2020

1 reference

TGFβ/TNFα-Mediated Epithelial–Mesenchymal Transition Generates Breast Cancer Stem Cells with a Claudin-Low Phenotype

31 March 2020

1 reference

Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties

31 March 2020

1 reference

Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells

31 March 2020

1 reference

A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations

31 March 2020

1 reference

A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment

31 March 2020

1 reference

Tumor necrosis factor-alpha blocks apoptosis in melanoma cells when BRAF signaling is inhibited

31 March 2020

1 reference

TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer

31 March 2020

1 reference

Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor

31 March 2020

1 reference

Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development

31 March 2020

1 reference

The cadherin switch in melanoma instigated by HGF is mediated through epithelial-mesenchymal transition regulators

31 March 2020

1 reference

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.

31 March 2020

1 reference

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

31 March 2020

1 reference

A multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastoma

31 March 2020

1 reference

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer

31 March 2020

1 reference

An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance

31 March 2020

1 reference

Macrophage diversity enhances tumor progression and metastasis

31 March 2020

1 reference

Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity.

31 March 2020

1 reference

Macrophage plasticity and polarization: in vivo veritas

31 March 2020

1 reference

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

31 March 2020

1 reference

Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia

31 March 2020

1 reference

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape

31 March 2020

1 reference

Blockade of programmed death ligand 1 enhances the therapeutic efficacy of combination immunotherapy against melanoma

31 March 2020

1 reference

PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokines

31 March 2020

1 reference

Interferon-γ links ultraviolet radiation to melanomagenesis in mice

31 March 2020

1 reference

The parallel lives of angiogenesis and immunosuppression: cancer and other tales

31 March 2020

1 reference

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells.

31 March 2020

1 reference

Neuropilin 1 deficiency on CD4 Foxp3 regulatory T cells impairs mouse melanoma growth

31 March 2020

1 reference

Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes.

31 March 2020

1 reference

Chromosomal instability and cancer: a complex relationship with therapeutic potential

31 March 2020

1 reference

Evolution of cooperation among tumor cells

31 March 2020

1 reference

A Functional Role for Tumor Cell Heterogeneity in a Mouse Model of Small Cell Lung Cancer

31 March 2020

1 reference

Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia.

31 March 2020

1 reference

Genetic variegation of clonal architecture and propagating cells in leukaemia

31 March 2020

1 reference

Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells.

31 March 2020

1 reference

31 March 2020

1 reference

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

31 March 2020

1 reference

Stochastic switching as a survival strategy in fluctuating environments

31 March 2020

1 reference

Imaging molecular pathways: reporter genes

31 March 2020

1 reference

Metabolic Tumor Imaging Using Magnetic Resonance Spectroscopy

31 March 2020

1 reference

A fully automated two-step synthesis of an (18)F-labelled tyrosine kinase inhibitor for EGFR kinase activity imaging in tumors

31 March 2020

1 reference

Cluster analysis and display of genome-wide expression patterns

31 March 2020

1 reference

Cancer attractors: a systems view of tumors from a gene network dynamics and developmental perspective

31 March 2020

1 reference

Transcriptome-wide noise controls lineage choice in mammalian progenitor cells

31 March 2020

1 reference

Functional roles for noise in genetic circuits

31 March 2020

1 reference

Cancer stem cells versus phenotype-switching in melanoma

31 March 2020

1 reference

Accumulation of driver and passenger mutations during tumor progression

31 March 2020

1 reference

The Therapeutic Implications of Plasticity of the Cancer Stem Cell Phenotype

31 March 2020

1 reference

Using Moment Equations to Understand Stochastically Driven Spatial Pattern Formation in Ecological Systems

31 March 2020

1 reference

Long-term single-cell imaging of mammalian stem cells

31 March 2020

1 reference

A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread

31 March 2020

1 reference

Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer

31 March 2020

1 reference

Epithelial to mesenchymal transition is a determinant of sensitivity to chemoradiotherapy in non-small cell lung cancer

31 March 2020

1 reference

Expression of selected gene for acquired drug resistance to EGFR-TKI in lung adenocarcinoma

31 March 2020

1 reference

Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks.

31 March 2020

1 reference

Systemic cancer progression and tumor dormancy: mathematical models meet single cell genomics

31 March 2020

1 reference

Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies

31 March 2020

1 reference

A race between tumor immunoescape and genome maintenance selects for optimum levels of (epi)genetic instability

31 March 2020

1 reference

Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23535846

12 December 2020

inferred from PubMed ID database lookup

"Hard" and "soft" lesions underlying the HLA class I alterations in cancer cells: implications for immunotherapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23535846

12 December 2020

inferred from PubMed ID database lookup

Growth interaction in vivo between tumor subpopulations derived from a single mouse mammary tumor

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23535846

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/NRC3498

1 reference

1 April 2018

release_umvzcvn5grafzi7v35ffjtbyqq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/umvzcvn5grafzi7v35ffjtbyqq

24 November 2022

mapped directly with Wikidata item

1 reference

1 April 2018